AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
T-CELL CLONAL EXPANSION IN PATIENTS WITH B-CELL LYMPHOPROLIFERATIVE DISORDERS
Authors: ALATRAKCHI N FARACE F FRAU E CARDE P MUNCK JN TRIEBEL F
Citation: N. Alatrakchi et al., T-CELL CLONAL EXPANSION IN PATIENTS WITH B-CELL LYMPHOPROLIFERATIVE DISORDERS, Journal of immunotherapy, 21(5), 1998, pp. 363-370
PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE IN PATIENTS WITH MANTLE-CELL LYMPHOMAS
Authors: DECAUDIN D BOSQ J TERTIAN G NEDELLEC G BENNACEUR A VENUAT AM BAYLE C CARDE P BENDAHMANE B HAYAT M MUNCK JN
Citation: D. Decaudin et al., PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE IN PATIENTS WITH MANTLE-CELL LYMPHOMAS, Journal of clinical oncology, 16(2), 1998, pp. 579-583
EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY
Authors: MOREAU P FLEURY J BRICE P COLOMBAT P BOUABDALLAH R LIOURE B VOILLAT L CASASNOVAS O FRANCOIS S SADOUN A LAMY T LOTZ JP MUNCK JN DIVINE M FERME C PENY AM FRUCHART C ORIOL P OJEDA M REMAN O MILPIED N GISSELBRECHT C LEGROS M HAROUSSEAU JL
Citation: P. Moreau et al., EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY, Bone marrow transplantation, 21(8), 1998, pp. 787-793
VIP (ETOPOSIDE, IFOSFAMIDE AND CISPLATINUM) AS A SALVAGE INTENSIFICATION PROGRAM IN RELAPSED OR REFRACTORY HODGKINS-DISEASE
Authors: RIBRAG V NASR F BOUHRIS JH BOSQ J BRAULT P GIRINSKY T COSSET JM MUNCK JN CORTI C DECAUDIN D PICO JL HAYAT M CARDE P
Citation: V. Ribrag et al., VIP (ETOPOSIDE, IFOSFAMIDE AND CISPLATINUM) AS A SALVAGE INTENSIFICATION PROGRAM IN RELAPSED OR REFRACTORY HODGKINS-DISEASE, Bone marrow transplantation, 21(10), 1998, pp. 969-974
PERCUTANEOUS MITOXANTRONE INJECTION FOR PRIMARY AND SECONDARY LIVER-TUMORS - PRELIMINARY-RESULTS
Authors: FARRES MT DEBAERE T LAGRANGE C RAMIREZ L ROUGIER P MUNCK JN ROCHE A
Citation: Mt. Farres et al., PERCUTANEOUS MITOXANTRONE INJECTION FOR PRIMARY AND SECONDARY LIVER-TUMORS - PRELIMINARY-RESULTS, Cardiovascular and interventional radiology, 21(5), 1998, pp. 399-403
LOW SPECIFICITY AND SENSITIVITY OF GA-67 SCAN IN THE EVALUATION OF POST CHEMOTHERAPY MEDIASTINAL RESIDUAL MASSES IN AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: ULUSAKARYA A MUNCK JN CASIRAGHI O KOSCIELNY S VANTELON JM DARTEVELLE P GIRINSKY T CARDE P PICO JL HAYAT M
Citation: A. Ulusakarya et al., LOW SPECIFICITY AND SENSITIVITY OF GA-67 SCAN IN THE EVALUATION OF POST CHEMOTHERAPY MEDIASTINAL RESIDUAL MASSES IN AGGRESSIVE NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 246-246
ELECTROCHEMOTHERAPY ON LIVER-TUMORS IN RABBITS
Authors: RAMIREZ LH ORLOWSKI S AN D BINDOULA G DZODIC R ARDOUIN P BOGNEL C BELEHRADEK J MUNCK JN MIR LM
Citation: Lh. Ramirez et al., ELECTROCHEMOTHERAPY ON LIVER-TUMORS IN RABBITS, British Journal of Cancer, 77(12), 1998, pp. 2104-2111
MAINTAINED ALL-TRANS-RETINOIC ACID THERAPY IN A PATIENT WITH PSEUDOTUMOR CEREBRI DESPITE AGGRAVATED SYMPTOMS
Authors: DECAUDIN D ADAMS D NACCACHE P CASTAGNA L MUNCK JN
Citation: D. Decaudin et al., MAINTAINED ALL-TRANS-RETINOIC ACID THERAPY IN A PATIENT WITH PSEUDOTUMOR CEREBRI DESPITE AGGRAVATED SYMPTOMS, Leukemia & lymphoma, 27(3-4), 1997, pp. 373-374
MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES
Authors: DECAUDIN D BOSQ J MUNCK JN BAYLE C KOSCIELNY S BOUDJEMAA S BENNACEUR A VENUAT AM NACCACHE P BENDAHMANE B RIBRAG V CARDE P PICO JL HAYAT M
Citation: D. Decaudin et al., MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES, Leukemia & lymphoma, 26(5-6), 1997, pp. 539
MAGNETIC-RESONANCE-IMAGING OF THE BONE-MARROW IN LYMPHOMAS AND LEUKEMIAS
Authors: TARDIVON AA VANEL D MUNCK JN BOSQ J
Citation: Aa. Tardivon et al., MAGNETIC-RESONANCE-IMAGING OF THE BONE-MARROW IN LYMPHOMAS AND LEUKEMIAS, Leukemia & lymphoma, 25(1-2), 1997, pp. 55-68
PREDICTIVE VALUE OF SERUM P53 ANTIBODIES IN PATIENTS WITH LARGE-CELL LYMPHOMAS RETROSPECTIVE ANALYSIS OF 40 PATIENTS
Authors: GIRINSKY T RIBRAG V BOSQ J KOSCIENLY S MUNCK JN CARDE P PICO JL LUBIN R BOURHIS JH DELARUE P
Citation: T. Girinsky et al., PREDICTIVE VALUE OF SERUM P53 ANTIBODIES IN PATIENTS WITH LARGE-CELL LYMPHOMAS RETROSPECTIVE ANALYSIS OF 40 PATIENTS, Blood, 90(10), 1997, pp. 3896-3896
ECVB - A NEW HIGH-DOSE CHOP REGIMEN FOLLOWED BY AN INTENSIVE CONSOLIDATION IN PATIENTS (PTS) AGED LESS-THAN-OR-EQUAL-TO-60 YEARS WITH AGGRESSIVE LYMPHOMA (NHL) PRESENTING WITH ONLY ONE ADVERSE PROGNOSTIC FACTOR OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) - AN INTERIM ANALYSIS OFTHE LNH93-2 PROTOCOL ON 433 PTS
Authors: MOREL P MUNCK JN COIFFIER B GISSELBRECHT C LEDERLIN P LAVAUD A BOSLY A TILLY H QUESNEL B THYSS A SCHLAIFER D BRIERE J REYES F
Citation: P. Morel et al., ECVB - A NEW HIGH-DOSE CHOP REGIMEN FOLLOWED BY AN INTENSIVE CONSOLIDATION IN PATIENTS (PTS) AGED LESS-THAN-OR-EQUAL-TO-60 YEARS WITH AGGRESSIVE LYMPHOMA (NHL) PRESENTING WITH ONLY ONE ADVERSE PROGNOSTIC FACTOR OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) - AN INTERIM ANALYSIS OFTHE LNH93-2 PROTOCOL ON 433 PTS, Blood, 90(10), 1997, pp. 2610-2610
ALTERNATING CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED-STAGE INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS FOR 96 PATIENTS WITH TUMORS GREATER-THAN-5 CM
Authors: MUNCK JN DHERMAIN F KOSCIELNY S GIRINSKY T CARDE P BOSQ J DECAUDIN D JULIERON M COSSET JM HAYAT M
Citation: Jn. Munck et al., ALTERNATING CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED-STAGE INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS FOR 96 PATIENTS WITH TUMORS GREATER-THAN-5 CM, Annals of oncology, 7(9), 1996, pp. 925-931
PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS
Authors: RAMIREZ LH ZHAO ZX ROUGIER P BOGNEL C DZODIC R VASSAL G ARDOUIN P GOUYETTE A MUNCK JN
Citation: Lh. Ramirez et al., PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS, Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 371-376
EVALUATION OF EXTENDED ADMINISTRATION OF ORAL ETOPOSIDE
Authors: MUNCK JN
Citation: Jn. Munck, EVALUATION OF EXTENDED ADMINISTRATION OF ORAL ETOPOSIDE, Bulletin du cancer, 83(5), 1996, pp. 352-360
SEMEN CRYOPRESERVATION AND POSTTHERAPEUTI C GONADAL DYSFUNCTION IN NON-HODGKINS DISEASE - EXPERIENCE AT THE INSTITUT GUSTAVE-ROUSSY FROM 1989 TO 1993
Authors: NACCACHE P DECAUDIN D KOSCIELNY S BENDAHMANE B AUGER J MUNCK JN
Citation: P. Naccache et al., SEMEN CRYOPRESERVATION AND POSTTHERAPEUTI C GONADAL DYSFUNCTION IN NON-HODGKINS DISEASE - EXPERIENCE AT THE INSTITUT GUSTAVE-ROUSSY FROM 1989 TO 1993, Bulletin du cancer, 83(4), 1996, pp. 307-314
MAMI SALVAGE THERAPY AND HIGH-DOSE CHEMOTHERAPY (HDCT) FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA (NHL)
Authors: BENDAHMANE B BOURHIS JH MUNCK JN KOSCIELNY S DECAUDIN D BRAULT P CASTAGNA L BOSQ J IBRAHIM A NACCACHE P ULUSAKARYA A PICO JL HAYAT M
Citation: B. Bendahmane et al., MAMI SALVAGE THERAPY AND HIGH-DOSE CHEMOTHERAPY (HDCT) FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA (NHL), Blood, 88(10), 1996, pp. 3852-3852
LONG-TERM FOLLOW-UP OF A SUPER CHVMP-VB REGIMEN IN PATIENTS WITH HIGH-RISK NON-HODGKINS-LYMPHOMA OF AGGRESSIVE HISTOLOGY
Authors: NACCACHE P MUNCK JN BRAULT P DECAUDIN D KOSCIELNY S BOSQ J BENNACEUR AL CARDE P PICO JL ULUZAKARYA A BOURHIS JH GILLES E HAYAT M
Citation: P. Naccache et al., LONG-TERM FOLLOW-UP OF A SUPER CHVMP-VB REGIMEN IN PATIENTS WITH HIGH-RISK NON-HODGKINS-LYMPHOMA OF AGGRESSIVE HISTOLOGY, Blood, 88(10), 1996, pp. 1796-1796
IS FLUDARABINE EFFICIENT IN MANTLE CELL LYMPHOMAS
Authors: DECAUDIN D MUNCK JN NEDELLEC G TERTIAN G BENDAHMANE B BENNACEUR AL BOSQ J ULUSAKARYA A CASTAGNA L BOURHIS JH PICO JL HAYAT M
Citation: D. Decaudin et al., IS FLUDARABINE EFFICIENT IN MANTLE CELL LYMPHOMAS, Blood, 88(10), 1996, pp. 2262-2262
CAN CLINICAL-DATA HELP TO SCREEN PATIENTS WITH LYMPHOMA FOR MR-IMAGING OF BONE-MARROW
Authors: TARDIVON AA MUNCK JN SHAPEERO LG KOSCIELNY S BOSQ J DHERMAIN F GILLES R HAYAT M VANEL D
Citation: Aa. Tardivon et al., CAN CLINICAL-DATA HELP TO SCREEN PATIENTS WITH LYMPHOMA FOR MR-IMAGING OF BONE-MARROW, Annals of oncology, 6(8), 1995, pp. 795-800
STIMULATION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY SURAMIN ON THE VX2 MODEL
Authors: RAMIREZ LH JULIERON M BONNAY M KOSCIELNY S ZHAO ZX GOUYETTE A MUNCK JN
Citation: Lh. Ramirez et al., STIMULATION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY SURAMIN ON THE VX2 MODEL, Investigational new drugs, 13(1), 1995, pp. 51-53
RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN ACUTE MYELOGENOUS LEUKEMIA
Authors: MUNCK JN DEACAUDIN D KOSCIELNY S
Citation: Jn. Munck et al., RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 333(17), 1995, pp. 1155-1156
SALVAGE TREATMENT OF RELAPSING LYMPHOMAS WITH A NON-MYELOTOXIC CHEMOTHERAPY COMBINING CISPLATINUM, BLEOMYCIN, METHYL GAG, AND PREDNISOLONE
Authors: BRAULT P GILLES E RIBRAG V BOURHIS JH MUNCK JN PICO JL HAYAT M
Citation: P. Brault et al., SALVAGE TREATMENT OF RELAPSING LYMPHOMAS WITH A NON-MYELOTOXIC CHEMOTHERAPY COMBINING CISPLATINUM, BLEOMYCIN, METHYL GAG, AND PREDNISOLONE, Bulletin du cancer, 82(12), 1995, pp. 1032-1037
PHASE-I STUDY OF CARBOPLATIN IN ASSOCIATION WITH CYTARABIN OR VP16 INTHE TREATMENT OF POOR-RISK ACUTE-LEUKEMIA
Authors: STOPPA AM MUNCK JN JOURDAN E BOUABDALLAH R BOULET JM ROSSI JF PICO J GASTAUT JA PELLAECOSSET B BLAISE D MARANINCHI D
Citation: Am. Stoppa et al., PHASE-I STUDY OF CARBOPLATIN IN ASSOCIATION WITH CYTARABIN OR VP16 INTHE TREATMENT OF POOR-RISK ACUTE-LEUKEMIA, Blood, 86(10), 1995, pp. 3117-3117
PHASE-I AND PHARMACOLOGICAL STUDY OF INTRAARTERIAL HEPATIC ADMINISTRATION OF PIRARUBICIN IN PATIENTS WITH ADVANCED HEPATIC METASTASES
Authors: MUNCK JN ROUGIER P CHABOT GG RAMIREZ LH BOGNEL C LUMBROSO J HERAIT P ELIAS D LASSER P GOUYETTE A
Citation: Jn. Munck et al., PHASE-I AND PHARMACOLOGICAL STUDY OF INTRAARTERIAL HEPATIC ADMINISTRATION OF PIRARUBICIN IN PATIENTS WITH ADVANCED HEPATIC METASTASES, European journal of cancer, 30A(3), 1994, pp. 289-294
Risultati: 1-25 | 26-32